Status:
UNKNOWN
Prenatal Carrier Screening for Spinal Muscular Atrophy Among Thai Pregnant Women
Lead Sponsor:
Mahidol University
Conditions:
Spinal Muscular Atrophy
Eligibility:
FEMALE
18+ years
Brief Summary
Spinal muscular atrophy (SMA) prenatal carrier screening is recommended by American College of Medical Genetics (ACMG) and American College of Obstetrics and Gynecology (ACOG). However, in Thailand, t...
Detailed Description
Spinal muscular atrophy (SMA) is one of the most common neuromuscular autosomal recessive disorders. The incidence is about 1:10,000 livebirths. There are 5 subgroups base on onset of symptoms and cli...
Eligibility Criteria
Inclusion
- Maternal age \> 18 years
- Singleton pregnancy
- Gestational age ≤ 14 weeks
Exclusion
- Refuse to participate the research trial
Key Trial Info
Start Date :
March 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04859179
Start Date
March 10 2021
End Date
March 1 2022
Last Update
April 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Ratchathewi, Bangkok, Thailand, 10400